Minerva Surgical Q3 EPS $(0.81) Beats $(1.00) Estimate, Sales $11.96M Miss $13.21M Estimate
Portfolio Pulse from Benzinga Newsdesk
Minerva Surgical (NASDAQ:UTRS) reported Q3 earnings with an EPS loss of $(0.81), which was better than the expected $(1.00) estimate. However, their sales of $11.96M fell short of the $13.21M estimate, marking a 4.95% decrease from the previous year.
November 13, 2023 | 10:05 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Minerva Surgical's Q3 EPS loss was better than expected, but sales missed estimates and showed a year-over-year decline.
The mixed results with a better-than-expected EPS but lower sales could lead to a neutral short-term impact on UTRS stock price. Investors may react positively to the reduced losses but may also be concerned about the sales miss and year-over-year decline.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100